McMurdo Marion E T, Bissett Linda Y, Price Rosemary J G, Phillips Gabby, Crombie Iain K
Section of Ageing and Health, Division of Medicine and Therapeutics, Department of Medical Microbiology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
Age Ageing. 2005 May;34(3):256-61. doi: 10.1093/ageing/afi101.
cranberry juice is often given to older people in hospital to prevent urinary tract infection (UTI), although there is little evidence to support its use.
to assess whether cranberry juice ingestion is effective in reducing UTIs in older people in hospital.
randomised, placebo-controlled, double-blind trial.
Medicine for the Elderly assessment and rehabilitation hospital wards.
376 older patients in hospital.
participants were randomised to daily ingestion of 300 ml of cranberry juice or matching placebo beverage. The primary outcome was time to onset of first UTI. Secondary outcomes were adherence to beverage drinking, courses of antibiotics prescribed, and organisms responsible for UTIs.
a total of 21/376 (5.6%) participants developed a symptomatic UTI: 14/189 in the placebo group and 7/187 in the cranberry juice group. These between-group differences were not significant, relative risk (RR) 0.51 [95% CI 0.21-1.22, P = 0.122). Although there were significantly fewer infections with Escherichia coli in the cranberry group (13 versus 4) RR 0.31 [95% CI 0.10-0.94, P = 0.027], this should be interpreted with caution as it was a secondary outcome.
despite having the largest sample size of any clinical trial yet to have examined the effect of cranberry juice ingestion, the actual infection rate observed was lower than anticipated, making the study underpowered. This study has confirmed the acceptability of cranberry juice to older people. Larger trials are now required to determine whether it is effective in reducing UTIs in older hospital patients.
蔓越莓汁常被用于医院中的老年人,以预防尿路感染(UTI),尽管几乎没有证据支持其使用。
评估摄入蔓越莓汁对降低住院老年人尿路感染的有效性。
随机、安慰剂对照、双盲试验。
老年医学评估与康复医院病房。
376名住院老年患者。
参与者被随机分为每日摄入300毫升蔓越莓汁组或匹配的安慰剂饮料组。主要结局是首次发生尿路感染的时间。次要结局包括饮料饮用依从性、开具的抗生素疗程以及导致尿路感染的病原体。
共有21/376(5.6%)的参与者发生了有症状的尿路感染:安慰剂组14/189,蔓越莓汁组7/187。组间差异不显著,相对风险(RR)为0.51[95%可信区间(CI)0.21 - 1.22,P = 0.122]。尽管蔓越莓汁组大肠杆菌感染明显较少(13例对4例),RR为0.31[95%CI 0.10 - 0.94,P = 0.027],但由于这是次要结局,应谨慎解读。
尽管该研究是所有考察摄入蔓越莓汁效果的临床试验中样本量最大的,但观察到的实际感染率低于预期,导致研究效能不足。本研究证实了蔓越莓汁对老年人的可接受性。现在需要更大规模的试验来确定其是否能有效降低老年住院患者的尿路感染。